Sarepta Therapeutics (SRPT) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.28% |
| Dec 31, 2025 | -8.11% |
| Sep 30, 2025 | 0.24% |
| Jun 30, 2025 | 24.73% |
| Mar 31, 2025 | -85.68% |
| Dec 31, 2024 | 18.52% |
| Sep 30, 2024 | 17.81% |
| Jun 30, 2024 | 15.43% |
| Mar 31, 2024 | 20.51% |
| Dec 31, 2023 | 31.75% |
| Sep 30, 2023 | 15.51% |
| Jun 30, 2023 | 33.08% |
| Mar 31, 2023 | -70.85% |
| Dec 31, 2022 | 72.00% |
| Sep 30, 2022 | -41.18% |
| Jun 30, 2022 | -29.28% |
| Mar 31, 2022 | -26.27% |
| Dec 31, 2021 | 3.44% |
| Sep 30, 2021 | 3.33% |
| Jun 30, 2021 | -5.59% |
| Mar 31, 2021 | -22.87% |
| Dec 31, 2020 | -23.94% |
| Sep 30, 2020 | -30.56% |
| Jun 30, 2020 | -29.07% |
| Mar 31, 2020 | 22.43% |
| Dec 31, 2019 | -39.35% |
| Sep 30, 2019 | -30.22% |
| Jun 30, 2019 | -55.61% |
| Mar 31, 2019 | -24.97% |
| Dec 31, 2018 | -33.95% |
| Sep 30, 2018 | -25.38% |
| Jun 30, 2018 | -44.73% |
| Mar 31, 2018 | -18.34% |
| Dec 31, 2017 | -20.24% |
| Sep 30, 2017 | -46.23% |
| Jun 30, 2017 | -63.23% |
| Mar 31, 2017 | 71.19% |
| Dec 31, 2016 | -58.46% |
| Sep 30, 2016 | -38.66% |
| Jun 30, 2016 | -44.25% |
| Mar 31, 2016 | -61.50% |
| Dec 31, 2015 | -108.11% |
| Sep 30, 2015 | -69.36% |
| Jun 30, 2015 | -40.77% |